[Retracted] Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases

Table 2

Comparison of HAMA and HAMD scores.

Groups	Case number	HAMA (points)		HAMD (points)
		Before treatment	After treatment	Before treatment	After treatment
Control subjects	54
Research group	50
	/	0.524	16.854	1.985	15.742
	/	>0.05	<0.05	>0.05	<0.05